CXCL8 and glioblastoma: IL-6 and IL-8 likely play pivotal roles in microenvironment-associated chemotherapeutic resistance in GBM [10]; therefore, using anti-inflammatory drugs in addition to cytotoxic drugs may result in more successful GBM treatments.